## Abstract 5‐Methoxy‐2‐methyl‐1‐(3,4‐methylenedioxybenzoyl)indole‐3‐acetic acid (ID‐955)(I), a new anti‐inflammatory agent, was labelled with carbon‐14 at C‐2 position of indole nucleus for the use of metabolic studies. The procedure used is shown in Fig. 1 and 2. Levulinic‐4‐^14^C acid was synthe
Synthesis of 14C-labeled 4-hydroxyindole as an intermediate for the preparation of (S)-2-[4-[2-[3-(indol-2-[14C]-4-yloxy)-2-hydroxypropylamino]-2-methylpropyl]-phenoxy]pyridine-5-carboxamide (LY368842-[indole-14C]) glycolate
✍ Scribed by Boris A. Czeskis; Dean K. Clodfelter; William J. Wheeler
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 102 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.631
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Synthesis of 4‐hydroxyindole labeled with ^14^C at the 2‐position was accomplished based on the vicarious nucleophilic substitution reaction of benzyl‐protected 3‐nitrophenol with p‐chlorophenoxyacetonitrile‐[1‐^14^C]. This was followed by the reductive cyclization of o‐nitrocyanomethyl derivative by palladium catalyzed hydrogenation. p‐Chlorophenoxyacetonitrile‐[1‐^14^C] was prepared from commercially available p‐chlorophenoxymethyl chloride and sodium cyanide‐[^14^C]. 4‐Hydroxyindole‐[2‐^14^C] was used for the synthesis of ^14^C‐labeled β~3~ adrenergic agonist LY368842. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
We have synthesized 14C-and 2H-labeled 1,3-dihydro-3,3dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H\_-indol-2one (LY195115), an extremely potent, orally-effective cardiotonic with inotropic and vasodilator activities. '\*C-label was introduced in the antepenultimate step by reaction of a B-